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Background
Ventilator-induced lung injury (VILI) increases lung
endothelial permeability. Lung endothelial nitric oxide
(NO) generation contributed to this increased permeabil-
ity in an intact mouse model of VILI [1]. NO stimulates
endothelial soluble guanylyl cyclase (sGC) to produce
cGMP. The effect of cGMP on endothelial permeability is
controversial [2]. We sought to determine 1) if endothe-
lial cGMP is generated in VILI and 2) if changes in
endothelial cGMP modulate VILI-induced endothelial
barrier dysfunction.
Methods
Isolated C57BL6 mouse lungs (n = 2–6 per group) were
ventilated with 21% O2, 5% CO2 at a rate of 120 breaths/
minute at tidal volumes (TV) of 0, 6, 15 or 20 ml/kg and
perfused with a constant flow of physiologic buffer (with
3% albumin). We measured serial perfusate cGMP con-
centrations (with IBMX) and assessed permeability by the
filtration coefficient (Kf; without IBMX). The sGC inhibi-
tor ODQ and the NO-independent sGC activator Bay 41–
2272 were used to manipulate sGC activity; atrial natriu-
retic peptide (ANP) was used to stimulate particulate GC
(pGC) activity.
Results
By 80 min of ventilation, perfusate cGMP increased as a
function of time and TV with a maximal increase of 24-
fold occurring with 15 ml/kg TV. Kf was unchanged with
6 and 15 ml/kg TV (Kf = 0.8 ± 0.3 ml/min/mmHg/100 g)
but was increased 6-fold with 20 ml/kg TV indicating VILI.
ODQ attenuated cGMP production and eliminated the
increased Kf in 20 ml/kg lungs (Kf = 0.8 ± 0.3 ml/min/
mmHg/100 g) suggesting sGC/cGMP-mediated barrier
dysfunction. Consistent with this, Bay 41–2272 (1.5 μM)
administered at 40 min of perfusion further increased per-
fusate cGMP and markedly exacerbated Kf in 15 ml/kg
lungs by 9-fold but neither the low Kf in 6 ml/kg TV lungs
nor high Kf in 20 ml/kg TV lungs were affected. The
adverse Bay 41–2272 effects on cGMP and Kf could be
prevented by ODQ pretreatment ruling out a nonspecific
drug effect. Underscoring the apparent injurious interac-
tion of sGC activity and lung stretch, the administration of
the same Bay 41–2272 dose 10 min before increasing TV
to 15 ml/kg had no effect on Kf after 80 min at this TV (Kf
= 1.2 ± 0.5 ml/min/mmHg/100 g) compared to diluent
control. Moreover, these effects were specific to sGC,
because pGC activation with atrial natriuretic peptide
(ANP) did not affect Kf whether administered before or
after the onset of injurious ventilation.
Conclusion
These data suggest that endogenous lung endothelial
cGMP increases from sGC stimulation in VILI and con-
tributes to VILI-induced endothelial barrier dysfunction.
The mechanism of this injurious effect appears to require
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an interaction between sGC and lung stretch because 1)
an increased level of stretch for a critical period of time
was required before sGC activation resulted in endothelial
barrier dysfunction and 2) pGC stimulation had no effect.
Based on these data we speculate that ventilatory stretch
may shift the subcellular location of endothelial sGC to a
compartment where cGMP production increases endothe-
lial permeability.
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